Kamal Adawi Sells $24.4K of Exagen Inc (XGN) — SEC Form 4, Mar 06, 2024
Open-Market Net Sale · SEC Form 4
−$24,407
Equity position changed by -5.0%
Equity Position
244K sh
256,533 → 243,749
Equity Change
-5.0%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Kamal Adawi CIK 0001788393 |
CFO
|
Kamal Adawi at Exagen Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Exagen Inc
| 2024-02-22 | Award | — | View |
| 2024-02-08 | Sell | -$13,133 | View |
| 2023-03-03 | Sell | -$8,432 | View |
| 2023-03-01 | Award | — | View |
| 2023-02-10 | Sell | -$15,671 | View |
Non-Derivative Securities Transactions
Footnotes (2)
- F1
- The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 1, 2023. Show more
- F2
- The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2021. Show more
Related filings at Exagen Inc
Institutional Holders
13F holders · Jun 30, 2026
57
institutional managers reporting a position
Largest by reported value
- Wexford Capital Lp $3.69M
- Nano Cap New Millennium Growth Fund L P $3.14M
- Vanguard Capital Management Llc $2.85M
5%+ Holders · 13D/G
3 filers
-
Parian Ultreia LP 5.3%
-
Chernett Jorey 9.9%
Other insiders at Exagen Inc
-
Jorey Chernett +$104K
-
John Aballi -$270K
-
Jeffrey G. Black -$149K
-
Paul Kim —
GET /v1/forms/4/0001274737-24-000017
API docs
View Original SEC Filing